7 April 2022 - This document outlines 51 recommendations from the Life Saving Drugs Expert Panel review. ...
1 April 2022 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the December 2021 PBAC ...
25 March 2022 - The utilisation analysis public release documents from the October 2021 DUSC meeting are now available. ...
18 March 2022 - The Public Summary Documents (first time rejections and deferrals) from the November 2021 PBAC meeting are now ...
4 March 2022 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the November 2021 PBAC ...
28 January 2022 - Measuring and valuing health-related quality of life in children can be challenging but is an important component ...
14 January 2022 - The Public Summary Documents (first time rejections and deferrals) from the September 2021 PBAC meeting are now ...
24 December 2021 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the September 2021 PBAC ...
24 December 2021 - The PBS Expenditure and Prescriptions Report 1 July 2020 to 30 June 2021 is now available. ...
24 December 2021 - The report on the collection of under co-payment data 2020-21 is now available. ...
1 December 2021 - In an open-access publication in the Journal of European CME, two authors from IQWiG argue that ...
25 November 2021 - A new parliamentary report ‘The New Frontier: Delivering better health for all Australians’ is recommending significant ...
24 November 2021 - The outcome statement for the semaglutide stakeholder meeting held on 26 August 2021 is now available. ...
12 November 2021 - The Public Summary Documents (first time rejections and deferrals) from the July 2021 PBAC meeting are now ...
5 November 2021 - The Outcome Statement from the October 2021 Drug Utilisation SubCommittee meeting is now available. ...